市場調查報告書

感染疾病診斷:全球市場的展望(2018-2027年)

Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

出版商 Stratistics Market Research Consulting 商品編碼 939198
出版日期 內容資訊 英文 131 Pages
商品交期: 2-3個工作天內
價格
感染疾病診斷:全球市場的展望(2018-2027年) Infectious Disease Diagnostics - Global Market Outlook (2018-2027)
出版日期: 2020年05月01日內容資訊: 英文 131 Pages
簡介

全球感染疾病診斷的市場在預測期間內預計將以7.1%的年複合成長率推移,從2018年的155億3000萬美元,成長到2027年287億9000萬美元的規模。感染疾病盛行率的增加,新技術的開發與R&D活動的活躍,抑制感染疾病的新診斷檢驗增加等要素促進了該市場的成長。可是同時,熟練的技術人員·專家的不足,及設備的高成本性阻礙了市場更進一步的增長。

本報告提供全球感染疾病診斷的市場調查,彙整市場及技術概要,市場成長的各種影響因素及市場機會分析,產品&服務·技術·檢驗類型·疾病區分·終端用戶·地區/主要國家等各種區分趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊。

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 簡介
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 技術分析
  • 終端用戶分析
  • 新興市場
  • Covid-19的影響

第4章 波特的五力分析

第5章 全球感染疾病診斷市場:各類產品·服務

  • 簡介
  • 化驗·套件·試劑
  • 設備
  • 軟體

第6章 全球感染疾病診斷市場:各檢驗類型

  • 簡介
  • 切片檢查
  • 影像檢查
  • 臨床檢驗

第7章 全球感染疾病診斷市場:各技術

  • 簡介
  • 生物化學的特性評估
  • 臨床微生物學
  • 傳統技術
  • DNA微陣列
  • DNA序列&下一代序列(NGS)
  • 雜合反應·微陣列
  • 免疫診斷
  • 恆溫核酸增幅技術(INAAT)
  • 顯微鏡
  • 分子技術
  • POC感染疾病診斷檢驗
  • 聚合酵素鏈鎖反應(PCR)

第8章 全球感染疾病診斷市場:各疾病種類

  • 簡介
  • 後天性免疫機能喪失症候群(AIDS)
  • 細菌感染
  • 心血管感染疾病
  • 披衣菌感染性器官感染疾病·淋病(CT / NG)
  • 冠狀病毒
  • 腺性熱
  • 肝炎
  • 院內感染(HAIS)
  • 人免疫力缺乏病毒(HIV)
  • 人類乳突病毒(HPV)
  • 流感
  • 抗藥性金黃色葡萄球菌(MRSA)
  • 結核(TB)
  • 其他

第9章 全球感染疾病診斷市場:各終端用戶

  • 簡介
  • 學術/ 調查機關
  • 門診病人手術中心
  • 血庫
  • 受託調查機關
  • 診斷診所
  • 家庭醫療保健
  • 醫院/臨床檢驗室
  • 護養設施
  • 醫生辦公室
  • 索引實驗室

第10章 全球感染疾病診斷市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第11章 主要展開

  • 契約·聯盟·合作·JV
  • M&A
  • 新產品的銷售
  • 擴張
  • 其他主要策略

第12章 企業簡介

  • Abbott Diagnostic
  • Alere
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • bioMerieux
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Corgenix
  • Diasorin
  • Diaxonhit
  • Eiken Chemical
  • EMD Millipore
  • J.Mitra
  • Meridian Bioscience
  • Roche Diagnostic
  • Siemens Healthcare Diagnostics
  • TECHLAB
  • Thermo Fisher Scientific
  • Trinity Biotech
目錄

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period. Increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases are the major factors propelling the market growth. However, lack of skilled technicians/professionals and high cost of these devices is hampering the market growth.

Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.

Based on the technology, DNA sequencing & next-generation sequencing (NGS) segment is going to have a lucrative growth during the forecast period due to factors such as development in sequencing technologies, rising awareness and taking of personalized medicine in which this technology has major applications and growing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future. By geography, North America is likely to have a huge demand owing to extremely developed healthcare system, mounting prevalence of infectious diseases, the existence of a huge number of leading national clinical laboratories, and simple accessibility to technologically advanced devices in the region.

Some of the key players profiled in the Infectious Disease Diagnostics Market are Abbott Diagnostic, Alere, Beckman Coulter , Becton, Dickinson and Company (BD), bioMerieux, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diasorin, Diaxonhit , Eiken Chemical, EMD Millipore, J.Mitra, Meridian Bioscience, Roche Diagnostic , Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific and Trinity Biotech.

Product & Services Covered:

  • Assays, Kits, & Reagents
  • Instruments
  • Software

Test Types Covered:

  • Biopsies
  • Imaging Test
  • Laboratory Tests

Technologies Covered:

  • Biochemical Characterization
  • Clinical Microbiology
  • Conventional Techniques
  • DNA Microarray
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • Hybridization and Microarrays
  • Immunodiagnostics
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microscopy
  • Molecular Techniques
  • POC infectious disease diagnostics test
  • Polymerase Chain Reaction (PCR)

Disease Types Covered:

  • Acquired Immunodeficiency Syndrome (AIDS)
  • Bacterial Infection
  • Cardiovascular infection
  • Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • Coronavirus
  • Glandular fever
  • Hepatitis
  • Hospital-Acquired Infections (HAIS)
  • Human Immunodeficiency Virus (HIV)
  • Human Papillomavirus (HPV)
  • Influenza
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Tuberculosis (TB)
  • Other Disease Types

End Users Covered:

  • Academic/Research Institutes
  • Ambulatory Surgical Centers
  • Blood Banks
  • Contract Research Organization
  • Diagnostic Clinics
  • Home healthcare
  • Hospital/Clinical Laboratories
  • Nursing Homes
  • Physician Offices
  • Reference Laboratories

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product & Service

  • 5.1 Introduction
  • 5.2 Assays, Kits, & Reagents
  • 5.3 Instruments
  • 5.4 Software

6 Global Infectious Disease Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Biopsies
  • 6.3 Imaging Test
  • 6.4 Laboratory Tests

7 Global Infectious Disease Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Biochemical Characterization
  • 7.3 Clinical Microbiology
  • 7.4 Conventional Techniques
  • 7.5 DNA Microarray
  • 7.6 DNA Sequencing & Next-Generation Sequencing (NGS)
  • 7.7 Hybridization and Microarrays
  • 7.8 Immunodiagnostics
  • 7.9 Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 7.10 Microscopy
  • 7.11 Molecular Techniques
  • 7.12 POC infectious disease diagnostics test
  • 7.13 Polymerase Chain Reaction (PCR)

8 Global Infectious Disease Diagnostics Market, By Disease Type

  • 8.1 Introduction
  • 8.2 Acquired Immunodeficiency Syndrome (AIDS)
  • 8.3 Bacterial Infection
  • 8.4 Cardiovascular infection
  • 8.5 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • 8.6 Coronavirus
  • 8.7 Glandular fever
  • 8.8 Hepatitis
  • 8.9 Hospital-Acquired Infections (HAIS)
  • 8.10 Human Immunodeficiency Virus (HIV)
  • 8.11 Human Papillomavirus (HPV)
  • 8.12 Influenza
  • 8.13 Methicillin-resistant Staphylococcus Aureus (MRSA)
  • 8.14 Tuberculosis (TB)
  • 8.15 Other Disease Types

9 Global Infectious Disease Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Academic/Research Institutes
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Blood Banks
  • 9.5 Contract Research Organization
  • 9.6 Diagnostic Clinics
  • 9.7 Home healthcare
  • 9.8 Hospital/Clinical Laboratories
  • 9.9 Nursing Homes
  • 9.10 Physician Offices
  • 9.11 Reference Laboratories

10 Global Infectious Disease Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Diagnostic
  • 12.2 Alere
  • 12.3 Beckman Coulter
  • 12.4 Becton, Dickinson and Company (BD)
  • 12.5 bioMerieux
  • 12.6 Bio-Rad Laboratories
  • 12.7 Cavidi
  • 12.8 Cepheid
  • 12.9 Corgenix
  • 12.10 Diasorin
  • 12.11 Diaxonhit
  • 12.12 Eiken Chemical
  • 12.13 EMD Millipore
  • 12.14 J.Mitra
  • 12.15 Meridian Bioscience
  • 12.16 Roche Diagnostic
  • 12.17 Siemens Healthcare Diagnostics
  • 12.18 TECHLAB
  • 12.19 Thermo Fisher Scientific
  • 12.20 Trinity Biotech

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product & Service (2017-2027) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays, Kits, & Reagents (2017-2027) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Software (2017-2027) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2017-2027) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2017-2027) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2017-2027) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2017-2027) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2017-2027) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Conventional Techniques (2017-2027) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By DNA Microarray (2017-2027) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2017-2027) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By Hybridization and Microarrays (2017-2027) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2017-2027) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2017-2027) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By Molecular Techniques (2017-2027) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By POC infectious disease diagnostics test (2017-2027) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2017-2027) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2017-2027) ($MN)
  • Table 25 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (2017-2027) ($MN)
  • Table 26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular infection (2017-2027) ($MN)
  • Table 27 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2017-2027) ($MN)
  • Table 28 Global Infectious Disease Diagnostics Market Outlook, By Coronavirus (2017-2027) ($MN)
  • Table 29 Global Infectious Disease Diagnostics Market Outlook, By Glandular fever (2017-2027) ($MN)
  • Table 30 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis (2017-2027) ($MN)
  • Table 31 Global Infectious Disease Diagnostics Market Outlook, By Hospital-Acquired Infections (HAIS) (2017-2027) ($MN)
  • Table 32 Global Infectious Disease Diagnostics Market Outlook, By Human Immunodeficiency Virus (HIV) (2017-2027) ($MN)
  • Table 33 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2017-2027) ($MN)
  • Table 34 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2017-2027) ($MN)
  • Table 35 Global Infectious Disease Diagnostics Market Outlook, By Methicillin-resistant Staphylococcus Aureus (MRSA) (2017-2027) ($MN)
  • Table 36 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (TB) (2017-2027) ($MN)
  • Table 37 Global Infectious Disease Diagnostics Market Outlook, By Other Disease Types (2017-2027) ($MN)
  • Table 38 Global Infectious Disease Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 39 Global Infectious Disease Diagnostics Market Outlook, By Academic/Research Institutes (2017-2027) ($MN)
  • Table 40 Global Infectious Disease Diagnostics Market Outlook, By Ambulatory Surgical Centers (2017-2027) ($MN)
  • Table 41 Global Infectious Disease Diagnostics Market Outlook, By Blood Banks (2017-2027) ($MN)
  • Table 42 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2017-2027) ($MN)
  • Table 43 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Clinics (2017-2027) ($MN)
  • Table 44 Global Infectious Disease Diagnostics Market Outlook, By Home healthcare (2017-2027) ($MN)
  • Table 45 Global Infectious Disease Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2017-2027) ($MN)
  • Table 46 Global Infectious Disease Diagnostics Market Outlook, By Nursing Homes (2017-2027) ($MN)
  • Table 47 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2017-2027) ($MN)
  • Table 48 Global Infectious Disease Diagnostics Market Outlook, By Reference Laboratories (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.